The Cooper Companies, Inc.
Financials
Valuation Metrics
The Cooper Companies, Inc.'s Market Cap is $10.49B. At end of 2025 it was $16.12B. Ranked #892 of 3,121 in US market (top 29%), #282 of 1,463 on NASDAQ (top 19%), #61 of 205 in Health Care Equipment & Services (top 30%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $10.49B | US#892/3,121 Sec#61/205 |
| Revenue | $4.24B | US#977/3,121 Sec#57/205 |
| Net Income | $570M | US#775/3,121 Sec#43/205 |
| Total Assets | $12.67B | US#858/3,121 Sec#40/205 |
| Net Assets | $8.33B | US#495/3,121 Sec#26/205 |
| Employees | 15,000 | US#676/3,121 Sec#53/205 |
| Value | ||
| P/E | 18.39x | US#1,018/3,121 Sec#21/205 |
| P/B | 1.26x | US#650/3,121 Sec#30/205 |
| PEG | 0.46x | US#586/3,121 Sec#23/205 |
| P/S | 2.48x | US#1,491/3,121 Sec#104/205 |
| EV/EBITDA | 14.15x | US#1,441/3,121 Sec#52/205 |
| FCF Yield | 0.86% | US#2,200/3,121 Sec#133/205 |
| Profitability | ||
| ROE | 6.85% | US#1,700/3,121 Sec#82/205 |
| ROA | 4.50% | US#1,140/3,121 Sec#74/205 |
| Op. Margin | 12.85% | US#1,368/3,121 Sec#54/205 |
| Revenue Growth | 4.73% | US#1,831/3,121 Sec#136/205 |
| Earnings Growth | 39.85% | US#585/3,121 Sec#31/205 |
| Financial Health | ||
| Debt Ratio | 52.17% | US#595/3,121 Sec#66/205 |
| Total Debt | $2.54B | US#1,037/3,121 Sec#48/205 |
| FCF | $91M | US#1,772/3,121 Sec#104/205 |
| Cash | $155M | US#1,943/3,121 Sec#118/205 |
| Current Ratio | 1.22x | US#1,975/3,121 Sec#169/205 |
| Net Debt/EBITDA | 2.63x | US#1,501/3,121 Sec#92/205 |
| Dividend | ||
| Div. Growth | 0.00% | US—/3,121 Sec—/205 |
| Performance | ||
| 1Y Return | -16.42% | US#2,311/3,121 Sec#158/205 |
| 1M Return | -29.04% | US#3,075/3,121 Sec#202/205 |
| From 52W High | -40.15% | US#2,467/3,121 Sec#162/205 |
| 1Y MDD | -36.82% | US#1,847/3,121 Sec#103/205 |
| Trading | ||
| Volume | 4,967,176 shares | US#344/3,121 Sec#16/205 |
| Trading Value | $267M | US#345/3,121 Sec#25/205 |
| Per Share | ||
| EPS | $2.92 | US#1,077/3,121 Sec#56/205 |
| BPS | $42.68 | US#563/3,121 Sec#38/205 |
Company Info
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.